Peri-implant Vitamin D and Cathelicidin (LL-37) Levels
Evaluation of Peri-Implant Sulcus Fluid Vitamin D and Cathelicidin (LL-37) Levels in Peri-Implant Health and Diseases
Evaluation of Peri-Implant Sulcus Fluid Vitamin D and Cathelicidin (LL-37) Levels in Peri-Implant Health and Diseases
Sponsor study identifier
observational
33
1 country
1
Study Start
April 1, 2021
Actual (reported)Primary Completion
December 1, 2021
Actual (reported)Study Completion
December 1, 2021
Actual (reported)This research aims to explore the influence of vitamin D on the body's defense system by examining its impact on specific proteins involved in immune response and inflammation in the soft tissues surrounding dental implants. Also aims to determine how vitamin D levels affect these proteins and their role in protecting peri-implant tissues from microbial infections and inflammation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2021
Actual (reported)December 1, 2021
Actual (reported)December 1, 2021
Actual (reported)March 3, 2025
Actual (reported)March 10, 2025
Actual (reported)Peri-implant sulcus fluid vitamin D levels and clinical parameters correlation
The association between vitamin D levels in peri-implant sulcus fluid and clinical parameters in individuals with peri-implant health and peri-implant diseases.
At the day of visit (Day 0)- Peri-implant clinical assessments and peri-implant sulcus fluid collection
The correlation between vitamin D and the antimicrobial peptide LL-37
Peri-implant sulcus fluid Vitamin d and LL-37 levels were investigated with ELISA
Laboratory tests were completed after all samples were collected.
Mucosal Inflammation
Measurement of mucosal inflammation around implants using modified plaque index (mPI), and modified sulcus bleeding index (mSBI).
At the day of visit (Day 0)
Probing Pocket Depth
Measurement of the periodontal pockets depth around implants. Unit of Measure: Millimeters (mm)
At the day of visit (Day 0)
Width of Keratinized Mucosa
Measurement of the width of keratinized mucosa around the implants. Unit of Measure: Millimeters (mm)
A total of 105 dental implants from 33 patients were assessed, with 35 categorized in the peri-implant health group, 35 in the peri-implant mucositis group, and 35 in the peri-implantitis group.
In vitro studies have shown that vitamin D promotes the release of antimicrobial peptides from gingival epithelial cells, no clinical research has specifically examined its effect on LL-37 levels in peri-implant tissue diseases. This study seeks to investigate the relationship between vitamin D levels in peri-implant sulcus fluid and clinical parameters in individuals with both peri-implant health and disease. Additionally, it aims to assess the correlation between vitamin D and the antimicrobial peptide LL-37.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
This cross-sectional clinical study included 33 patients with dental implants, exhibiting either healthy peri-implant tissues or peri-implant diseases, who sought treatment at the Department of Periodontology, Faculty of Dentistry, Altınbaş University.
Altinbas University
Istanbul, BAKIRKOy, 34147, Turkey (Türkiye)
Peri-implant sulcus fluid
ILKNUR OZENCI, Dr
Altinbas University
33 participants (actual enrollment reported by the registry).
First Submitted
March 3, 2025
First Posted
March 10, 2025
Study Start
April 1, 2021
Actual (reported)Evaluation of Implantoplasty in the Treatment of Peri-Implantitis.
At the day of visit (Day 0)
Contact the study team to confirm eligibility.
Primary Completion
December 1, 2021
Actual (reported)Study Completion
December 1, 2021
Actual (reported)Last Updated
March 10, 2025
Record last verified: 2025-03
This detailed description provides a comprehensive overview of your study, outlining its objectives, background, methodology, and expected outcomes in a structured and academic manner.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: